Holen Sie sich die Stockscreener-App
2.36
2.61%
0.06
Handel nachbörslich:
2.36
Schlusskurs vom Vortag:
$2.30
Offen:
$2.29
24-Stunden-Volumen:
550.61K
Relative Volume:
0.84
Marktkapitalisierung:
$166.92M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-1.5733
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
+0.85%
1M Leistung:
-3.28%
6M Leistung:
-40.10%
1J Leistung:
-57.93%
1-Tages-Spanne:
$2.2863
$2.445
1-Wochen-Bereich:
$2.19
$2.445
52-Wochen-Spanne:
$2.015
$5.92
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.36 | 162.68M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Health Catalyst, MongoDB, Asana, Domo, and RingCentral Stocks Trade Up, What You Need To Know - Yahoo Finance
Why Clinical Data Analytics Is Becoming One of Healthcare’s Fastest-Growing Markets? - GlobeNewswire Inc.
Q3 Earnings Highs And Lows: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks - Yahoo Finance
Nasdaq Moves: What are Health Catalyst Incs recent SEC filings showingMarket Movers & Daily Chart Pattern Signals - baoquankhu1.vn
Health Catalyst, Veeva Systems, 8x8, Amplitude, and DocuSign Stocks Trade Down, What You Need To Know - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Kura Oncology (KURA), Health Catalyst (HCAT) - The Globe and Mail
Market Outlook: Can Health Catalyst Inc stock weather global recessionStop Loss & Risk Managed Investment Strategies - Bộ Nội Vụ
Health Catalyst stock reiterated as Buy at Stifel despite 2026 revenue guide - Investing.com
HCAT Projects Strong Client Growth and EBITDA Goals for FY25 - GuruFocus
(HCAT) Health Catalyst Expects 2025 Revenue to Slightly Exceed Guidance of About $310 Million - marketscreener.com
Health Catalyst drives AI in healthcare to cut costs - Traders Union
Surprises Report: Is Health Catalyst Inc stock a top pick in earnings seasonJuly 2025 Outlook & Verified Swing Trading Watchlists - moha.gov.vn
Health Catalyst examines AI's tangible impact on healthcare - Traders Union
4 Analysts Have This To Say About Health Catalyst - Benzinga
HCAT: Citigroup Adjusts Price Target, Maintains Neutral Rating | - GuruFocus
Is Health Catalyst Inc. stock positioned well for digital economyWalking Comfort Picks & what to check before ordering - Улправда
Is Health Catalyst Inc. stock a top pick in earnings seasonJuly 2025 PreEarnings & Low Risk High Win Rate Picks - Улправда
How Health Catalyst Inc. stock compares to growth peers2025 Fundamental Recap & AI Powered Market Entry Strategies - Улправда
Can Health Catalyst Inc. stock rebound after recent weaknessMarket Rally & AI Driven Stock Movement Reports - Улправда
Is Health Catalyst Inc. stock a dividend growth opportunityJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - Улправда
Is Health Catalyst Inc. stock oversold or undervaluedMarket Risk Summary & Technical Pattern Alert System - Улправда
EPS Watch: Is Health Catalyst Inc stock positioned well for digital economy2025 Market Sentiment & Free Expert Approved Momentum Trade Ideas - Bộ Nội Vụ
3 Russell 2000 Stocks Walking a Fine Line - Finviz
3 Value Stocks We Find Risky - Finviz
Signal Recap: Is Health Catalyst Inc stock oversold or undervaluedGap Down & Weekly High Return Stock Opportunities - moha.gov.vn
Investor Mood: Can Health Catalyst Inc stock rebound after recent weaknessWeekly Stock Analysis & Safe Entry Point Identification - Bộ Nội Vụ
3 Stocks Under $10 We're Skeptical Of - Finviz
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Bollinger Band Squeeze Points to Volatility in Winsome Textile Industries LimitedOptions Trading Strategies & Fast Profit Capital Growth - earlytimes.in
What analysts say about Health Catalyst Inc stockCandlestick Trading Patterns & Minimal Investment Profits - earlytimes.in
Health Catalyst Insider Ups Holding By 109% During Year - Yahoo Finance
Is Health Catalyst Inc. stock a buy before product launchesJuly 2025 Update & Weekly High Momentum Picks - Улправда
Health Catalyst, IncCommon stock (NQ: HCAT - FinancialContent
Will Health Catalyst Inc. (2YP) stock outperform global peersJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - Улправда
Why Health Catalyst Inc. stock is a must watch in 2025Market Performance Report & Momentum Based Trading Signals - Улправда
Would You Still Hold Health Catalyst Stock If It Fell 30%? - Trefis
Death Cross: How Health Catalyst Inc. stock trades during market volatility2025 Market Outlook & Community Shared Stock Ideas - Улправда
Is Health Catalyst Inc. (2YP) stock attractive for growth fundsTrade Analysis Summary & Community Supported Trade Ideas - Улправда
New Program Aims to Strengthen Community Health Tech in NWA - arkansasbusiness.com
HubSpot, nCino, Rapid7, and Health Catalyst Stocks Trade Down, What You Need To Know - Finviz
New Innovation Program to Strengthen Community Health Tech Economy in Northwest Arkansas - PR Newswire
Health Catalyst (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 27,425 Shares - MarketBeat
Health Catalyst (NASDAQ:HCAT) Director Sells $128,151.99 in Stock - MarketBeat
Dir Larson-Green Sells 47,997 ($128.3K) Of Health Catalyst Inc [HCAT] - TradingView — Track All Markets
Health Catalyst's Market Cap Drops To US$190m Leaving Insiders With Losses - simplywall.st
What technical patterns form on Health Catalyst Inc. (2YP) stock chartsWeekly Market Outlook & Precise Buy Zone Tips - Newser
How Health Catalyst Inc. (2YP) stock behaves in tightening cyclesLong Setup & Weekly Market Pulse Alerts - Newser
Is Health Catalyst Inc. (2YP) stock positioned for digital growth era2025 Market Overview & Fast Moving Stock Watchlists - Newser
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
2.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):